Johnson & Johnson
Johnson & Johnson（JNJ）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · JNJ · 截至 2026年6月8日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
21
近12个月
买卖比
0.05
Buy/Sell (by trades)
整体情绪
Johnson & Johnson内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
JNJ 季度内部人买卖趋势
JNJ 内幕交易卖出 · JNJ 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · JNJ CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
JNJ 高管卖出股份 · JNJ 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 1, 2026 | REED JOHN C EVP, Innovative Medicine, R&D | Option | 25,255 | — | Form 4 |
| May 1, 2026 | REED JOHN C EVP, Innovative Medicine, R&D | Other | 11,002 | $2.53M⚡ | Form 4 |
| Feb 27, 2026 | Decker Robert J VP Corporate Controller | Option | 4,075 | $471K | Form 4 |
| Feb 27, 2026 | Decker Robert J VP Corporate Controller | Sale | 4,075 | $1.01M⚡ | Form 4 |
| Feb 20, 2026 | Schmid Timothy EVP, WW Chair, MedTech | Sale | 1,322 | $325K | Form 4 |
| Feb 13, 2026 | Swanson James D. EVP, CIO | Option | 22,191 | $3.61M⚡ | Form 4 |
| Feb 17, 2026 | Swanson James D. EVP, CIO | Option | 20,521 | $3.38M⚡ | Form 4 |
| Feb 13, 2026 | Swanson James D. EVP, CIO | Option | 19,368 | $3.21M⚡ | Form 4 |
| Feb 13, 2026 | Swanson James D. EVP, CIO | Option | 9,412 | — | Form 4 |
| Feb 15, 2026 | Swanson James D. EVP, CIO | Option | 709 | — | Form 4 |
| Feb 17, 2026 | Swanson James D. EVP, CIO | Sale | 20,521 | $4.98M⚡ | Form 4 |
| Feb 15, 2026 | Swanson James D. EVP, CIO | Other | 309 | $75K | Form 4 |
| Feb 15, 2026 | Swanson James D. EVP, CIO | Option | 492 | — | Form 4 |
| Feb 15, 2026 | Swanson James D. EVP, CIO | Other | 214 | $52K | Form 4 |
| Feb 13, 2026 | Swanson James D. EVP, CIO | Sale | 22,191 | $5.41M⚡ | Form 4 |
| Feb 13, 2026 | Swanson James D. EVP, CIO | Other | 3,547 | $867K | Form 4 |
| Feb 13, 2026 | Swanson James D. EVP, CIO | Sale | 19,368 | $4.72M⚡ | Form 4 |
| Feb 13, 2026 | Swanson James D. EVP, CIO | Option | 447 | — | Form 4 |
| Feb 13, 2026 | Swanson James D. EVP, CIO | Other | 143 | $35K | Form 4 |
| Feb 13, 2026 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option | 13,706 | — | Form 4 |
| Feb 15, 2026 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option | 635 | — | Form 4 |
| Feb 15, 2026 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Other | 325 | $79K | Form 4 |
| Feb 15, 2026 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Option | 606 | — | Form 4 |
| Feb 15, 2026 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Other | 310 | $75K | Form 4 |
| Feb 13, 2026 | Wengel Kathryn E EVP, Chief TO and Risk Officer | Other | 6,414 | $1.57M⚡ | Form 4 |
REED JOHN C
EVP, Innovative Medicine, R&D
日期
May 1
股数
11,002
均价
$229.85
总金额
$2.53M ⚡
Wengel Kathryn E
EVP, Chief TO and Risk Officer
日期
Feb 15
股数
325
均价
$243.45
总金额
$79K
Wengel Kathryn E
EVP, Chief TO and Risk Officer
日期
Feb 15
股数
310
均价
$243.45
总金额
$75K
Wengel Kathryn E
EVP, Chief TO and Risk Officer
日期
Feb 13
股数
6,414
均价
$244.55
总金额
$1.57M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 JNJ 内幕交易
JNJ 内幕交易
Johnson & Johnson（JNJ）内幕交易数据来源于公司内部人（包括Wolk Joseph J (Exec VP, CFO), Swanson James D. (EVP, CIO), Wengel Kathryn E (EVP, Chief TO and Risk Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。JNJ内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Johnson & Johnson机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
JNJ 内幕交易 · 5个问题Johnson & Johnson（JNJ）的内部人包括高管和董事，如Wolk Joseph J (Exec VP, CFO), Swanson James D. (EVP, CIO), Wengel Kathryn E (EVP, Chief TO and Risk Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026